Transgenomic to acquire Annovis

Genomic supplier company TBIO will acquire specialty chemical play Annovis (San Jose, Calif.) for 1.9 million shares of TBIO, equal to $13.4 million based on TBIO's Tuesday closing price of $7.04, and...